NOVEL DRUG REIMBURSEMENT MODELS: LESSONS AND IMPLICATIONS FROM CANCER DRUG ACCESS SCHEMES

被引:0
|
作者
Aggarwal, S. [1 ]
机构
[1] Novel Hlth Strategies, Bethesda, MD USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A361 / A361
页数:1
相关论文
共 50 条
  • [1] EMERGING DRUG REIMBURSEMENT MODELS: LESSONS AND IMPLICATIONS FROM CANCER DRUG ACCESS SCHEMES
    Aggarwal, S.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A298 - A299
  • [2] NOVEL REIMBURSEMENT MODELS FOR CANCER DRUG MARKET ACCESS (2010-2013)
    Aggarwal, S.
    Topaloglu, H.
    Messenger, M.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A153 - A153
  • [3] ORPHAN DRUG REIMBURSEMENT IN ENGLAND AND IMPLICATIONS FOR PATIENT ACCESS
    Walker, S.
    Lilley, H.
    Payne, R.
    Fountain, D.
    [J]. VALUE IN HEALTH, 2019, 22 : S859 - S859
  • [4] Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World
    Goldstein, Daniel A.
    Sarfaty, Michal
    [J]. ONCOLOGIST, 2016, 21 (08): : 907 - 909
  • [5] Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models
    Baker, Katie E.
    Bonvini, Sara J.
    Donovan, Chantal
    Foong, Rachel E.
    Han, Bing
    Jha, Aruni
    Shaifta, Yasin
    Smit, Marieke
    Johnson, Jill R.
    Moir, Lyn M.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 29 (02) : 181 - 198
  • [6] Colorectal cancer models for novel drug discovery
    Golovko, Daniel
    Kedrin, Dmitriy
    Yilmaz, Oemer H.
    Roper, Jatin
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (11) : 1217 - 1229
  • [7] Evaluation of indirect comparisons used for reimbursement decisions: Lessons from the Common Drug Review
    Vicente, C.
    Piwko, C.
    Chou, R.
    Maturi, B.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A49 - A49
  • [8] CANCER DRUG PRICES IN THE UNITED STATES AND THE UNITED KINGDOM: IMPLICATIONS FOR PRICING STRATEGY AND DRUG ACCESS
    Aggarwal, S.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A466 - A466
  • [9] THE SHARP DECREASE OF DRUG'S ACCESS TO REIMBURSEMENT IN FRANCE IN 2011
    Hounkanlin, H.
    Troubat, A.
    Vigier, Morlet D.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A309 - A309
  • [10] Xenograft models for preclinical drug testing: Implications for adrenocortical cancer
    Luconi, Michaela
    Mannelli, Massimo
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 351 (01) : 71 - 77